Use of Aspirin, NSAIDs Correlates with Improved Overall Survival in Colorectal Cancer
Regular use of NSAIDs after diagnosis of colorectal cancer correlated with improved survival in survivors with KRAS wild-type tumors.
Regular use of NSAIDs after diagnosis of colorectal cancer correlated with improved survival in survivors with KRAS wild-type tumors.
Researchers compared the effectiveness of NSAIDs, aspirin, and several nutritional supplements for the prevention of recurrent adenomatous neoplasia after colon polyp removal.
Regular aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) may lower the long-term risk of colorectal cancer (CRC), new study data suggests.
A recent meta-analysis demonstrated an association between aspirin and a reduced risk of prostate cancer.
Recurrence of hormone-related breast cancer was reduced by 50% in overweight and obese women who regularly used aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs), according to newly published data.